HU190513B - Process for producing of new preparates consisting of hydrogenised ergot-alcaloids and hepharine with therapeutical effect - Google Patents

Process for producing of new preparates consisting of hydrogenised ergot-alcaloids and hepharine with therapeutical effect Download PDF

Info

Publication number
HU190513B
HU190513B HU834202A HU420283A HU190513B HU 190513 B HU190513 B HU 190513B HU 834202 A HU834202 A HU 834202A HU 420283 A HU420283 A HU 420283A HU 190513 B HU190513 B HU 190513B
Authority
HU
Hungary
Prior art keywords
molecular weight
component
heparin
pharmaceutically acceptable
low molecular
Prior art date
Application number
HU834202A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT34124A (en
Inventor
Hans Buehlmann
Dieter Welzel
Original Assignee
Sandoz,Ag,Ch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz,Ag,Ch filed Critical Sandoz,Ag,Ch
Publication of HUT34124A publication Critical patent/HUT34124A/hu
Publication of HU190513B publication Critical patent/HU190513B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU834202A 1982-12-10 1983-12-08 Process for producing of new preparates consisting of hydrogenised ergot-alcaloids and hepharine with therapeutical effect HU190513B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3245695 1982-12-10

Publications (2)

Publication Number Publication Date
HUT34124A HUT34124A (en) 1985-02-28
HU190513B true HU190513B (en) 1986-09-29

Family

ID=6180290

Family Applications (1)

Application Number Title Priority Date Filing Date
HU834202A HU190513B (en) 1982-12-10 1983-12-08 Process for producing of new preparates consisting of hydrogenised ergot-alcaloids and hepharine with therapeutical effect

Country Status (25)

Country Link
JP (1) JPH0672101B2 (da)
AT (1) AT382514B (da)
AU (1) AU570658B2 (da)
BE (1) BE898356A (da)
CA (1) CA1224416A (da)
CH (1) CH656533A5 (da)
CY (1) CY1509A (da)
DD (1) DD215469B3 (da)
DK (1) DK162475C (da)
FR (1) FR2537435B1 (da)
GB (1) GB2131691B (da)
GR (1) GR79745B (da)
HK (1) HK23290A (da)
HU (1) HU190513B (da)
IE (1) IE56366B1 (da)
IL (1) IL70406A (da)
IT (1) IT1172368B (da)
LU (1) LU85127A1 (da)
NL (1) NL8304221A (da)
NZ (1) NZ206523A (da)
PH (1) PH23451A (da)
PT (1) PT77803B (da)
SE (1) SE468973B (da)
SG (1) SG53989G (da)
ZA (1) ZA839200B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432661A1 (de) * 1984-09-05 1986-03-06 Albert Prof. Dr. 6907 Nußloch Landsberger Carcinom-therapeutikum
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE441142B (sv) * 1975-12-04 1985-09-16 Sandoz Ag Forfarande for framstellning av ett terapeutiskt preparat med antitrombotiska egenskaper
DE2554533C3 (de) * 1975-12-04 1984-08-30 Sandoz-Patent-Gmbh, 7850 Loerrach Verwendung von Dihydroergotamin und Heparin
DE2809618A1 (de) * 1978-03-06 1979-09-20 Sandoz Ag Neues therapeutisches praeparat und verfahren zu dessen herstellung
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
SE8306792D0 (sv) 1983-12-08
JPS59116222A (ja) 1984-07-05
IE56366B1 (en) 1991-07-03
HUT34124A (en) 1985-02-28
DD215469B3 (de) 1988-03-09
IL70406A (en) 1988-08-31
IT8349456A0 (it) 1983-12-07
DK162475C (da) 1992-05-11
PT77803A (en) 1984-01-01
CH656533A5 (de) 1986-07-15
CY1509A (en) 1990-08-03
JPH0672101B2 (ja) 1994-09-14
FR2537435B1 (fr) 1987-03-20
PH23451A (en) 1989-08-07
DK565783D0 (da) 1983-12-08
IT1172368B (it) 1987-06-18
HK23290A (en) 1990-04-06
PT77803B (en) 1986-04-17
SG53989G (en) 1989-12-29
AU2222183A (en) 1984-06-14
SE468973B (sv) 1993-04-26
AT382514B (de) 1987-03-10
DD215469A5 (de) 1984-11-14
GB2131691B (en) 1986-12-03
GB2131691A (en) 1984-06-27
BE898356A (fr) 1984-06-04
NL8304221A (nl) 1984-07-02
GR79745B (da) 1984-10-31
IE832896L (en) 1984-06-10
DK565783A (da) 1984-06-11
LU85127A1 (fr) 1984-10-22
AU570658B2 (en) 1988-03-24
GB8332653D0 (en) 1984-01-11
SE8306792L (sv) 1984-06-11
FR2537435A1 (fr) 1984-06-15
ZA839200B (en) 1985-07-31
DK162475B (da) 1991-11-04
ATA428483A (de) 1986-08-15
IL70406A0 (en) 1984-03-30
CA1224416A (en) 1987-07-21
NZ206523A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
EP0546018B1 (en) Pharmaceutical composition of florfenicol
BRPI0310094B1 (pt) composto de bis-(monoetanolamina) de ácido 3'-[(2z)-[1-(3,4-dimetilfenil)-1,5-diidro-3-metil-5-oxo-4h-pirazol-4-ilideno]hidrazino]-2'-hidróxi-[1,1'-bifenil]-3-carboxílico, composição farmacêutica e processos para preparar ditos composto e composição farmacêutica
GB2220949A (en) Aerosol composition comprising nitroglycerin as active ingredient
EP1713466B1 (en) Antiparasitic composition containing an organic amine salt of closantel
EP0143478B1 (en) Stable, aqueous, acidic solution of cis-platinum, suitable for injection
CA1302278C (en) Injection solutions of torasemide which are ready to use and processes for their preparation thereof
EP0833640A1 (en) Pharmaceutical composition containing lamotrigine
US20080261939A1 (en) Stannsoporfin compositions and administration
IE871522L (en) Compositions for suppositories.
HU190513B (en) Process for producing of new preparates consisting of hydrogenised ergot-alcaloids and hepharine with therapeutical effect
EP0778772A1 (en) Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
WO2000013707A1 (fr) Medicaments preventifs/et remedes contre la defaillance de plusieurs organes
JPS6245524A (ja) ナトリウムフエニトイン水性製剤
RU2038080C1 (ru) Лекарственное средство для парентерального введения
JPH021126B2 (da)
WO2006107806A2 (en) Stannsoporfin compositions and administration
JPH0366617A (ja) 静脈内投与用フエニトインナトリウム製剤
EP1508332A1 (en) Medicinal composition
KR900002745B1 (ko) 안정 주사용 진토제 조성물의 제조방법
JP4611029B2 (ja) 非経口投与用のイホスファミド組成物及びその製造方法
KR100738021B1 (ko) 은행엽 엑스 고농도 함유 주사제
EP0420193A2 (en) Use of hydroxyurea or 1-ethyl-hydroxyurea for the suppression of bone marrow cells before transplantation

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee